Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants

被引：27
作者：
Olomu N. [1 ]
Kulkarni R. [2 ]
Manco-Johnson M. [3 ]
机构：
[1] Dept. of Pediatr./Human Development, Division of Neonatology, Michigan University, East Lansing, MI 48909-7980
[2] Dept. of Pediatr./Human Development, Division of Hematology-Oncology, Michigan State University, East Lansing, MI
[3] Mountain States Regional Hemophilia, Thrombosis Center, Univ. of Colorado Hlth. Sci. Center, Aurora, CO
来源：
Journal of Perinatology | 2002年 / 22卷 / 8期
关键词：
D O I：
10.1038/sj.jp.7210787
中图分类号：
学科分类号：
摘要：
Clinically apparent pulmonary hemorrhage (PH) occurs in 5% to 7% of very low birth weight (VLBW) infants with respiratory distress syndrome (RDS). It is associated with mortality rate as high as 50% and significant pulmonary and central nervous system morbilities. There is no consensus on treatment modality. We present two VLBW infants with severe PH that did not respond to conventional treatment but were successfully treated with activated recombinant factor VII (rRVIIa). No untoward side effects were noted.
引用
收藏
页码：672 / 674
页数：2
相关论文
共 50 条
  • [1] Treatment of severe pulmonary hemorrhage in very low birth weight infants with activated recombinant factor VII
    Olomu, IN
    Kulkarni, R
    Manco-Johnson, MJ
    PEDIATRIC RESEARCH, 2002, 51 (04) : 414A - 414A
  • [2] Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage
    Brady, Kenneth M.
    Easley, R. Blaine
    Tobias, Joseph D.
    PEDIATRIC ANESTHESIA, 2006, 16 (10) : 1042 - 1046
  • [3] Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa)
    S. Segal
    I. Y. Shemesh
    R. Blumenthal
    B. Yoffe
    N. Laufer
    Y. Ezra
    I. Levy
    M. Mazor
    U. Martinowitz
    Archives of Gynecology and Obstetrics, 2003, 268 (4) : 266 - 267
  • [4] Recombinant Activated Factor VIIa (rFVIIa) Treatment in Very-Low-Birth-Weight (VLBW) Premature Infants with Acute Pulmonary Hemorrhage: A Single-Center, Retrospective Study
    Hese Cosar
    Halil Isik
    Salih Cagrı Cakır
    Nese Yar
    Bulent Goksen
    Hakan Tokbay
    Hasan Kertmen
    Nihal Erdoğan
    Ikbal Durak
    Pediatric Drugs, 2017, 19 : 53 - 58
  • [5] Recombinant Activated Factor VIIa (rFVIIa) Treatment in Very-Low-Birth-Weight (VLBW) Premature Infants with Acute Pulmonary Hemorrhage: A Single-Center, Retrospective Study
    Cosar, Hese
    Isik, Halil
    Cakir, Salih Cagri
    Yar, Nese
    Goksen, Bulent
    Tokbay, Hakan
    Kertmen, Hasan
    Erdogan, Nihal
    Durak, Ikbal
    PEDIATRIC DRUGS, 2017, 19 (01) : 53 - 58
  • [6] Treatment of intrapulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight (VLBW) infants on mechanical ventilation in a community level III neonatal intensive care unit (NICU).
    Olomu, N
    Kulkarni, R
    Mano-Johnson, M
    BLOOD, 2001, 98 (11) : 262A - 263A
  • [7] Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
    Aggarwal A.
    Malkovska V.
    Catlett J.P.
    Alcorn K.
    Thrombosis Journal, 2 (1)
  • [8] Hemostasis in severe postpartum hemorrhage - The effect of recombinant activated factor VII (RFVIIA)
    Segal, S
    Shemesh, IY
    Yoffe, B
    Laufer, N
    Mankuta, D
    Mazor, M
    Zohar, S
    Shiff, E
    Ben-Tal, O
    Pauzner, D
    Martinowitz, U
    THROMBOSIS RESEARCH, 2005, 115 : 141 - 141
  • [9] Recombinant activated factor VII (rFVIIa) in the treatment of four cases of severe hemorrhage from portal hypertension (PH)
    Romero, R
    Pellicer, F
    Jimenez, M
    Gomez, M
    Sendon, A
    Guerrero, MD
    Herrerias, JM
    GASTROENTEROLOGY, 2002, 122 (04) : A79 - A79
  • [10] Massive pulmonary hemorrhage and severe retinopathy of prematurity in very low birth weight infants
    Lee, Na Young
    Lee, Hyun Young
    Park, Shin Hae
    Sung, In Kyung
    Youn, YoungAh
    TURKISH JOURNAL OF PEDIATRICS, 2017, 59 (06) : 636 - 641
12345